All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec005}
============

Response rates in health research have been declining over the past decades \[[@pone.0218658.ref001], [@pone.0218658.ref002]\]. This decline is concerning, especially because low response rates can lead to systematic differences in population characteristics between participants and non-respondents \[[@pone.0218658.ref003]--[@pone.0218658.ref005]\]. These differences in characteristics, hereafter referred to as non-response bias, could result in biased study outcomes \[[@pone.0218658.ref001], [@pone.0218658.ref002], [@pone.0218658.ref006], [@pone.0218658.ref007]\]. Strategies, such as data weighting techniques, can be used to reduce non-response bias, but the extent to which these strategies minimize bias is dependent on the availability of data on all potential factors that might be associated with non-response \[[@pone.0218658.ref008]\]. This highlights the importance of gaining insight into key factors of non-response.

Most studies exploring key factors of non-response examined differences in demographic characteristics between participants and non-respondents. These studies found that females, highly educated, or older individuals (\> 24 years), are usually more likely to participate in health research than males, lower educated, or younger individuals (≤ 24 years) \[[@pone.0218658.ref003], [@pone.0218658.ref005], [@pone.0218658.ref008], [@pone.0218658.ref009]\]. Fewer studies also compared behavioral characteristics of participants and non-respondents. In sexual health-related research, these studies found that low-risk individuals, in terms of lower number of sexual partners or less often previously diagnosed with a sexually transmitted infection (STI), were less likely to participate than high-risk individuals \[[@pone.0218658.ref005], [@pone.0218658.ref010], [@pone.0218658.ref011]\]. One study explored psychological characteristics in sexual health research context and found that non-respondents had less reward dependent and more harm-avoidant personalities than participants \[[@pone.0218658.ref012]\]. These findings suggest that identifying key factors of non-response should not be limited to only demographic characteristics.

In addition to low response rates during recruitment, loss to follow-up in longitudinal cohort studies could also lead to non-response bias when characteristics and health outcomes of participants lost to follow-up are different from the participants who are retained in the study \[[@pone.0218658.ref013]--[@pone.0218658.ref015]\]. Previous research indicated that certain demographic characteristics related to non-response at recruitment, such as lower education or low socioeconomic status, were also associated with loss to follow-up in longitudinal cohort studies \[[@pone.0218658.ref014], [@pone.0218658.ref015]\]. Although some empirical studies identified general psychological drivers behind participation in longitudinal studies \[[@pone.0218658.ref016], [@pone.0218658.ref017]\], such as positive attitudes towards participating in surveys, few such studies were conducted in sexual health-related research. One study in sexual health context, found that patients with poor knowledge of STI and a higher level of perceived STI-related stigma were more likely to be lost to follow-up from STI care \[[@pone.0218658.ref018]\]. However, this study was conducted in a low-resource setting and only included STI diagnosed individuals.

The objectives of this study were to identify demographic, sexual health-related, and behavioral predictors of non-response during recruitment, and to identify demographic, sexual health-related, behavioral, and psychological predictors of loss to follow-up. Data from a longitudinal cohort study in the Netherlands called \'Mathematical models incorporating Psychological determinants: control of Chlamydia Transmission\' (iMPaCT) offered a unique opportunity to analyze comprehensive information of both participants and non-participants during recruitment and loss to follow-up.

Materials and methods {#sec006}
=====================

Setting {#sec007}
-------

A detailed description of the study design can be found in the iMPaCT study protocol \[[@pone.0218658.ref019]\]. In short, the iMPaCT study explored the link between sexual behavior, psychological determinants, and chlamydia infections over a period of one year, using online questionnaires and information routinely registered by STI clinics. All heterosexual males and females, and females who have sex with both males and females, aged 18 to 24 years, making an appointment at the STI clinics of the public health services in Amsterdam, Kennemerland, Hollands Noorden, and Twente in the Netherlands from November 2016 to June 2017 were eligible to participate in the iMPaCT study. Two different recruitment strategies were used. At the STI clinics in Amsterdam, Kennemerland, and Hollands-Noorden, individuals were invited to participate in the iMPaCT study after finishing the online intake assessment for an STI test. After agreeing to participate and signing the online informed consent form, they were automatically redirected to the online questionnaire assessing psychological and behavioral determinants (see [S1](#pone.0218658.s004){ref-type="supplementary-material"} and [S2](#pone.0218658.s005){ref-type="supplementary-material"} Files for original and English translation of the questionnaire, and the invitation). At the STI clinic in Twente, it was only possible to make an appointment by telephone, and individuals were informed about the iMPaCT study at the end of the intake assessment. If they agreed to participate, they received an e-mail with the link to the informed consent and the online questionnaire. Individuals who agreed to participate, provided informed consent and started the baseline questionnaire will hereafter be referred to as *participants*, and all other eligible STI clinic visitors will be referred to as *non-respondents*.

Participants were enrolled for one year, and online questionnaires were administered at four different time points: baseline, three-week follow-up, six-month follow-up, and one-year follow-up. Furthermore, participants were tested for chlamydia using nucleic acid amplification tests (NAAT) at enrolment at the STI clinic and through a self-sampling kit sent to a laboratory at six-month follow-up. Participants were invited for all follow-up data collection moments, if they completed the baseline questionnaire and provided a valid email address. Participants could be temporarily lost to follow-up (i.e., completed questionnaire at six-month and one-year follow-up, but did not respond to the three-week follow-up questionnaire) or permanently (i.e., completed questionnaire at three-week follow-up, but did not respond to subsequent questionnaires).

Several passive recruitment strategies were used to increase response rates and retention in the iMPaCT study. First, the STI clinic visitors were informed of receiving a free of charge home-based test kit for chlamydia and gonorrhea after completing the questionnaire at six-month follow-up, and a monetary incentive after completing the questionnaire at one-year follow-up. Second, during follow-up the participants received two reminders per questionnaire by e-mail: one week and two weeks after the invitation for each follow-up questionnaire. The iMPaCT study was approved by the Medical Ethical Committee of the University Medical Centre Utrecht, the Netherlands (NL57481.094.16/METC18-363/D).

Data non-response at baseline {#sec008}
-----------------------------

The national STI surveillance database provided consultation data of all eligible STI clinic visitors during the recruitment period (November 2016---June 2017) in the four participating STI clinics. Participants were distinguished from the non-respondents in the consultation data using a unique iMPaCT study identification number. For individuals who visited the STI clinic more than once in the recruitment period, only the first consultation was included in the analyses, or, in case they agreed to participate in the iMPaCT study, the consultation linked to the iMPaCT questionnaire was included.

Demographic information obtained from the national STI surveillance database included age, gender (female/male), education level defined as highest attained degree or education currently enrolled in (low/medium: *no education*, *primary education only*, *lower general secondary education and vocational education*, high: *all other education levels*), STI clinic region (Amsterdam/Non-Amsterdam: *Hollands Noorden/Kennemerland/Twente*), and migration background (ethnic Dutch/non-Dutch). Migration background was based on the birth country of the participant and both parents consistent to the definitions used by Statistics Netherlands \[[@pone.0218658.ref020]\] and was categorized into two groups: Dutch (participant and both parents are born in the Netherlands) and non-Dutch (first-generation and second generation migrants from all other countries).Sexual health-related information included the STI test results at baseline (positive at any anatomic location/negative), type of STI test at baseline (regular consultation/self-sampling test kit), as well as STI-test in the past year, prior chlamydia/gonorrhea/syphilis diagnosis in the past year, and STI-related symptoms (all yes/no). Finally, the STI surveillance databases contained information on sexual behavior, including number of partners in the past six months, received partner notification (yes/no), and condom use most recent sex act (yes/no).

Data loss to follow-up {#sec009}
----------------------

For participants, additional data on behavioral and psychological data was available from the baseline online questionnaire. The development of the questionnaire has been described in detail in the iMPaCT study protocol \[[@pone.0218658.ref019]\]. Behavioral data included the number of sexual partners in the past six months, and age at sexual debut. Psychological data included perceived importance of (sexual) health or "*health goals"*, attitudes regarding prevention of chlamydia, intentions towards condom use and STI testing in the future, anticipated stigma, shame and anxiety with regard to chlamydia diagnosis, self-efficacy regarding condom use, expected social support after chlamydia diagnosis, subjective and social norms regarding condom use and STI testing, self-esteem, impulsiveness, risk perception, and knowledge regarding sexual health, prevention of chlamydia and consequences of chlamydia diagnosis.

The psychological characteristics were assessed on 5-point Likert scales, except for risk perception and knowledge. The 5-point Likert scales ranged from 1 (i.e., low level of the determinant) to 5 (i.e., high level of the determinant), and a mean score was calculated for all psychological scales. Risk perception was assessed on a scale from 0% to 100%. Risk perception for chlamydia *own risk* was defined as the mean of the participants' estimate of their own risk in the coming year and in their lifetime, and risk perception for chlamydia *peers' risk* was defined as the mean of the participants' estimate of the risk of their peers in the coming year and in their lifetime. Knowledge of sexual health in terms of prevention of chlamydia and consequences of chlamydia diagnosis, was assessed by six *true/false/I don't know* items, and was defined as the sum score of six items based on the number of correct answers (zero to six). Subjective and social norms, and social support were combined into one variable reflecting social environment. The score of each psychological determinant was divided in two categories at the median: low/median = lower than median, high = equal to or higher than median.

Statistical analyses {#sec010}
--------------------

To identify predictors for non-response at baseline, univariable and multivariable logistic regression analyses were performed using data from the national STI surveillance database on participants and non-respondents. All demographic, sexual health-related, and behavioral baseline characteristics were included in the univariable and multivariable analyses. Chlamydia positivity rates at baseline were compared between participants and non-respondents using a chi-squared test.

Predictors for loss to follow-up were also identified with univariable and multivariable logistic regression analyses, using data collected at baseline. The response to each follow-up moment was analyzed separately, as participants could be temporarily lost to follow-up. First, baseline characteristics were compared between participants who completed the questionnaire at three-week follow-up and participants who did not respond to the questionnaire invitation at three-week follow-up. Second, baseline characteristics were compared between participants who completed the questionnaire at six-month follow-up and participants who did not respond to the questionnaire invitation at six-month follow-up. Last, baseline characteristics were compared between participants who completed the questionnaire at one-year follow-up and participants who did not respond to the questionnaire invitation at one-year follow-up. In the univariable analyses, the baseline chlamydia test results, and the behavioral and psychological variables from the baseline questionnaire, were included in addition to the demographic, sexual health-related and behavioral variables from the national STI surveillance database. As the number of potential variables for the multivariable model was relatively high in relation to the sample size, the baseline variables included in the multivariable analyses were pre-selected in the univariable analyses using a p-value criterion of 0.1. Variables were excluded from the multivariable model if the number of observations per outcome category was too small in relation to the number of predictors \[[@pone.0218658.ref021]\]. If a variable was associated with loss to follow-up at either the three-week, six-month and/or one-year follow-up in the univariable analyses, it was included in all multivariable models.

All multivariable models (non-response and loss to follow-up) were constructed using a backward elimination procedure, based on the lowest Akaike information criterion (AIC) score. Interaction terms were added to the multivariable model, and if statistically significant, stratified analyses were shown. Missing values were included as a separate category if more than 5% of the observations were missing. Multicollinearity was evaluated using the Variance Inflation Factor (VIF) (VIF values above 5 indicating multicollinearity) \[[@pone.0218658.ref022]\], and variables that were highly correlated with other predictors were removed from the multivariable model. Goodness of fit of the model was examined using the Hosmer-Lemeshow (non-significant p-value indicating good fit) \[[@pone.0218658.ref023]\]. All statistical analyses were done using R version 3.4.0 \[[@pone.0218658.ref024]\].

Results {#sec011}
=======

Study population and response {#sec012}
-----------------------------

In total, 13,658 STI clinic visitors were eligible to participate in the iMPaCT study. The majority of those STI clinic visitors was ≥ 21 years (76%), female (72%), highly educated (71%), and ethnic Dutch (72%). Of those STI clinic visitors, 2,253 (16%) actively declined the online invitation, 1,705 (12%) agreed to participate, and 1,063 (8%) started the online questionnaire, and 933 (7%) completed the baseline questionnaire ([Fig 1](#pone.0218658.g001){ref-type="fig"}). The majority of the participants was ≥23 years old (52%), female (81%), highly educated (89%), and ethnic Dutch (81%). Furthermore, 79% of the participants were recruited at the STI clinic in Amsterdam (n = 838), 7% in Kennemerland (n = 81), 10% in Hollands Noorden (n = 105), and 4% in Twente (n = 39), resulting in response rates of 9%, 6%, 7%, and 3% respectively.

![Baseline response rates in the iMPaCT study.\
Abbreviations: STI = Sexually Transmitted Infection.](pone.0218658.g001){#pone.0218658.g001}

Of all participants who completed the baseline questionnaire), 810 participants could be invited to participate in the follow-up data collection moments. Of these 810 participants, 432 (53%) filled out the online questionnaire at three-week follow-up, 416 (51%) filled out the online questionnaire at six-month follow-up, and 344 (43%) filled out the last questionnaire at one-year follow-up ([Fig 2](#pone.0218658.g002){ref-type="fig"}). Furthermore, 26% of the participants completed all three follow-up questionnaires, 23% completed two follow-up questionnaires, 23% completed one follow-up questionnaire, and 28% did not respond to any of the follow-up questionnaires. All 416 participants who filled out the questionnaire at six-month follow-up received a home-based test kit, and 315 (76%) send the test kit to the laboratory for chlamydia and gonorrhea testing.

![Response participants invited for follow-up, at three-week, six-month, and one-year follow-up.\
Grey indicates (partial) lost to follow-up.](pone.0218658.g002){#pone.0218658.g002}

Predictors for non-response at baseline {#sec013}
---------------------------------------

All demographic, behavioral and sexual health-related variables were significant predictors of non-response in the univariable analysis ([Table 1](#pone.0218658.t001){ref-type="table"}). In the multivariable analysis, type of STI test was highly correlated to other explanatory variables as type of STI test is dependent on a number of predictors in the model (i.e., triage criteria, such as age, and migration background), and was therefore excluded from the model. In the final multivariable model, there was no multicollinearity (VIF values around 1), and the Hosmer-Lemeshow test indicated good fit (p-value = 0.3). Male gender, low/medium education level, young age (≤ 20 years), and being non-Dutch, were significant predictors of non-response at baseline. Furthermore, non-respondents were more likely to report STI-related symptoms, being notified by a partner, ≤ 2 partners in the past six months, and having had condomless sex at the last sex act compared to the participants. The chlamydia positivity rate at baseline was significantly higher (p = 0.003) in the non-respondents (n = 2,153, 17%) compared to the participants (n = 143, 14%).

10.1371/journal.pone.0218658.t001

###### Univariable and multivariable logistic regression analysis of predictors for non-response in the iMPaCT study by comparing participants (n = 1,063) and non-respondents (n = 12,595) aged 18--24 years visiting an STI clinic in November 2016 to June 2017.

![](pone.0218658.t001){#pone.0218658.t001g}

                                          *Participants*   *Non-respondents*                                            
  --------------------------------------- ---------------- ------------------- ------- ---- --------------------------- ------------------------
  Age                                                                                                                   
      18--20 years                        165              16                  3057    24   1                           1
      21--22 years                        342              32                  4567    36   **0.72 (0.59--0.87)**       **0.79 (0.65--0.96)**
      23--24 years                        556              52                  4971    40   **0.48 (0.40--0.58)**       **0.54 (0.45--0.65)**
  Gender                                                                                                                
      Female                              860              81                  9018    72   1                           1
      Male                                203              19                  3577    28   **1.68 (1.44--1.97)**       **1.73 (1.47--2.05)**
  Education level                                                                                                       
      Low/medium                          120              11                  3563    28   1                           1
      High                                941              89                  8692    69   **0.31 (0.26--0.38)**       **0.40 (0.32--0.48)**
  Migration background                                                                                                  
      Ethnic Dutch                        857              81                  8955    71   1                           1
      Non-Dutch                           206              19                  3638    29   **1.69 (1.45--1.98)**       **1.27 (1.08--1.49)**
  Symptoms                                                                                                              
      No                                  897              84                  9649    77   1                           1
      Yes                                 166              16                  2946    23   **1.65 (1.39--1.96)**       **1.35 (1.14--1. 62)**
  GO/CT/SYPH past year                                                                                                  
      No                                  320              30                  3092    24   1                           \-
      Yes                                 129              12                  1603    13   **1.29 (1.04--1.60)**       \-
      Not tested                          614              58                  7900    63   **1.33 (1.15--1.53)**       \-
  Partner notification                                                                                                  
      No                                  942              89                  10684   85   1                           1
      Yes                                 121              11                  1910    15   **1.39 (1.15--1.70)**       **1.23 (1.01--1.51)**
  Number of partners in past six months                                                                                 
      0--2 partners                       374              35                  6005    48   1                           1
      3--4 partners                       396              37                  3956    31   **0.62 (0.54--0.72)**       **0.66 (0.57--0.77)**
      ≥ 5 partners                        293              28                  2634    21   **0.56 (0.48--0.66)**       **0.55 (0.47--0.65)**
  Condom use at last sexual contact                                                                                     
      No                                  828              78                  10072   80   1                           1
      Yes                                 228              22                  2386    19   *0*.*86 (0*.*74--1*.*00)*   **0.83 (0.71--0.98)**

Footnote: Categories do not all add up to 100%, as missing values are not shown. Statistical associations are shown in in italic when the p-value is equal to or smaller than 0.1, and in bold when the p-value is equal to or smaller than 0.05.

Abbreviations: CT = Chlamydia; OR = crude odds ratio, aOR = adjusted odds ratio; CI = Confidence Interval; IC = Informed Consent; STI = Sexually Transmitted Infection; SYPH = Syphilis.

Predictors for loss to follow-up {#sec014}
--------------------------------

Interactions were found between STI clinic region (Amsterdam/non-Amsterdam) and the behavioral and psychological predictors. For these predictors, the analyses were stratified by STI region. Low/medium health goals at baseline was a significant predictor of non-response at six-month, and/or one-year follow-up in both Amsterdam ([Table 2](#pone.0218658.t002){ref-type="table"}) and non-Amsterdam region ([Table 3](#pone.0218658.t003){ref-type="table"}). Predictors of loss to follow-up in Amsterdam were low/medium social norms and support (at three-week follow-up), and having had ≥ 5 partners in the past six months (at six-month follow-up). For non-Amsterdam, high impulsiveness (at six-month follow-up), and high intentions (at one-year follow-up) were predictors of loss to follow-up. High risk perception at baseline in Amsterdam, and low/medium risk perception at baseline in non-Amsterdam was a significant predictor of loss to follow-up at six-month and one-year.

10.1371/journal.pone.0218658.t002

###### Multivariable logistic regression analyses of predictors of non-response at the three follow-up data collection moments for participants who visited the STI clinic in Amsterdam.

![](pone.0218658.t002){#pone.0218658.t002g}

                                                   *Baseline*   *3-week follow-up non-response*   *6-month follow-up non-response*   *1-year follow-up non-response*                                                                         
  ------------------------------------------------ ------------ --------------------------------- ---------------------------------- --------------------------------- ----------------------- ----- ---- ----------------------- ----- ---- ---------------------------
  Total                                            647                                            292                                45                                                        303   47                           365   56   
  Number of partners in past six months                                                                                                                                                                                                      
      0--2 partners                                222          34                                94                                 32                                \-                      93    31   1                       117   32   \-
      3--4 partners                                261          40                                123                                42                                \-                      114   38   0.99 (0.68--1.43)       143   39   \-
      ≥ 5 partners                                 164          25                                75                                 26                                \-                      96    32   **1.73 (1.14--2.64)**   105   29   \-
  Condom use at last sex act                                                                                                                                                                                                                 
      No                                           504          78                                235                                81                                \-                      239   79   \-                      300   82   1
      Yes                                          143          22                                57                                 20                                \-                      64    21   \-                      65    18   *0*.*70 (0*.*47--1*.*03)*
  Age at sexual debut                                                                                                                                                                                                                        
      \< 16 years                                  205          32                                102                                35                                \-                      100   33   \-                      123   34   \-
      ≥ 16 years                                   442          68                                190                                65                                \-                      203   67   \-                      242   66   \-
  Health goals                                                                                                                                                                                                                               
      Low/med (score \< 4.00)                      314          49                                159                                55                                1                       168   55   1                       200   55   1
      High (score ≥ 4.00)                          333          52                                133                                46                                0.77 (0.55--1.07)       135   45   **0.65 (0.47--0.90)**   165   45   **0.65 (0.47--0.90)**
  Attitudes[\*](#t002fn001){ref-type="table-fn"}                                                                                                                                                                                             
      Low/med (score \< 4.25)                      265          41                                136                                47                                1                       140   46   \-                      167   46   \-
      High (score ≥ 4.25)                          382          59                                156                                53                                0.76 (0.54--1.06)       163   54   \-                      198   54   \-
  Social norms and support                                                                                                                                                                                                                   
      Low/med (score \< 3.20)                      229          35                                122                                42                                1                       119   39   \-                      140   38   \-
      High (score ≥ 3.20)                          418          65                                170                                58                                **0.65 (0.47--0.91)**   184   61   \-                      225   62   \-
  Risk perception for CT (own risk)                                                                                                                                                                                                          
      Low/med (score \< 27.50)                     311          48                                134                                46                                \-                      126   42   1                       151   41   1
      High (score ≥ 27.50)                         336          52                                158                                54                                \-                      177   58   **1.51 (1.09--2.08)**   214   59   **1.70 (1.23--2.33)**

\* Attitudes regarding prevention of chlamydia

Footnote: Categories do not all add up to 100%, as missing values are not shown. Statistical associations are shown in in italic when the p-value is equal to or smaller than 0.1, and in bold when the p-value is equal to or smaller than 0.05. Only variables that were pre-selected in the univariable analyses are shown here.

Abbreviations: aOR = adjusted odds ratio, CI = Confidence Interval; Low/med = Low/medium, CT = Chlamydia; STI = Sexually Transmitted Infection.

10.1371/journal.pone.0218658.t003

###### Multivariable logistic regression analyses of predictors of non-response at the three follow-up data collection moments for participants who visited the STI clinics in Kennemerland, Hollands Noorden, and Twente (non-Amsterdam).

![](pone.0218658.t003){#pone.0218658.t003g}

                                                   *Baseline*   *3-week follow-up non-response*   *6-month follow-up non-response*   *1-year follow-up non-response*                                                                            
  ------------------------------------------------ ------------ --------------------------------- ---------------------------------- --------------------------------- --------------------------- ---- ---- ----------------------- ----- ---- -----------------------
  Total                                            163                                            86                                 53                                                            91   56                           101   62   
  Health goals                                                                                                                                                                                                                                  
      Low/med (score \< 4.00)                      83           51                                49                                 57                                1                           49   54   \-                      57    56   1
      High (score ≥ 4.00)                          80           49                                37                                 43                                *0*.*58 (0*.*31--1*.*08)*   42   46   \-                      44    44   **0.40 (0.18--0.75)**
  Intentions                                                                                                                                                                                                                                    
      Low/med (score \< 2.67)                      84           52                                44                                 51                                \-                          45   50   \-                      46    46   1
      High (score ≥ 2.67)                          79           48                                42                                 49                                \-                          46   51   \-                      55    55   **2.16 (1.08--4.44)**
  Impulsiveness                                                                                                                                                                                                                                 
      Low/med (score \< 2.63)                      78           48                                39                                 45                                \-                          35   39   1                       45    45   \-
      High (score ≥ 2.63)                          85           52                                47                                 55                                \-                          56   62   **2.97 (1.52--5.99)**   56    55   \-
  Knowledge[\*](#t003fn001){ref-type="table-fn"}                                                                                                                                                                                                
      Low/med (score \< 6.00)                      91           56                                48                                 56                                **-**                       56   62   1                       60    59   \-
      High (score ≥ 6.00)                          72           44                                38                                 44                                **-**                       35   39   0.58 (0.30--1.12)       41    41   \-
  Risk perception for CT (own risk)                                                                                                                                                                                                             
      Low/med (score \< 27.50)                     84           52                                44                                 51                                \-                          52   57   1                       58    57   1
      High (score ≥ 27.50)                         79           48                                42                                 49                                \-                          39   43   **0.45 (0.23--0.88)**   43    43   **0.47 (0.23--0.94)**

\* Knowledge regarding sexual health, prevention of chlamydia and consequences of chlamydia diagnosis

Footnote: Categories do not all add up to 100%, as missing values are not shown. Statistical associations are shown in in italic when the p-value is equal to or smaller than 0.1, and in bold when the p-value is equal to or smaller than 0.05. Only variables that were pre-selected in the univariable analyses are shown here.

Abbreviations: aOR = adjusted odds ratio, CI = Confidence Interval; Low/med = Low/medium, CT = Chlamydia; STI = Sexually Transmitted Infection.

Stratified multivariable analyses by STI clinic region using demographic and sexual health-related predictors was not possible due to the small number of observations in each cell ([S1](#pone.0218658.s001){ref-type="supplementary-material"} and [S2](#pone.0218658.s002){ref-type="supplementary-material"} Tables), and these predictors were analyzed separately without stratification. Male gender, low/medium education level, and younger age (≤ 20 years) were associated with non-response at either three-week, six-month and/or one-year follow-up ([S3 Table](#pone.0218658.s003){ref-type="supplementary-material"}). Chlamydia infection at baseline was not a predictor of loss to follow-up.

Discussion {#sec015}
==========

Our results showed that male, younger age (≤ 20 years), and low/medium educated individuals were more likely to be non-respondents at baseline and more likely to be lost to follow-up after baseline participation. Furthermore, behavioral and psychological variables appeared to play a role in non-response at long-term follow-up. Behavioral and psychological predictors of loss to follow-up were different between STI clinic regions, except for low perceived importance of health at baseline, which was predictive of loss to follow-up at six-month and one-year follow-up in all STI clinic regions. The chlamydia positivity rate was significantly higher among non-respondents than among the participants, but chlamydia infection itself at baseline was not a predictor of loss to follow-up.

The main strength of this study is the comprehensive data consisting of behavioral characteristics, sexual health outcomes and demographic characteristics on both participants and non-respondents. Moreover, to our knowledge, this is the first study identifying psychological predictors for loss to follow-up among both chlamydia diagnosed and undiagnosed heterosexual STI clinic visitors. Furthermore, the extensive non-response analysis provided insights into potential bias and generalizability of the study population. This study was, however, not without some limitations. First, reasons for non-response at baseline or loss to follow-up were not recorded. Nevertheless, reasons for non-response in health research, such as lack of time, being forgetful, or privacy concerns \[[@pone.0218658.ref010], [@pone.0218658.ref025]--[@pone.0218658.ref027]\], are well documented, and were not the purpose of this study. Second, the actual number of eligible STI clinic visitors who were invited for participation during the recruitment period was not known. As recruitment was only done through the online registration form at the STI clinics in Amsterdam, Kennemerland and Hollands Noorden, individuals who booked an appointment via telephone were not invited for participation (4%-17% of all eligible STI clinic visitors (M.S. van Rooijen, personal communication, October 17, 2018). At the STI clinic in Twente, no online registration exists, and recruitment was only done when people booked an appointment via telephone. However, not all eligible participants were invited due to lack of time or forgetting or omitting to inform eligible STI clinic visitors, but we were not able to distinguish invitees from non-invitees, meaning that actual response rates are higher.

We found that male gender, lower education, and a lower number of sexual partners were predictors of non-response, which was consistent with the literature \[[@pone.0218658.ref003], [@pone.0218658.ref005], [@pone.0218658.ref011], [@pone.0218658.ref028]--[@pone.0218658.ref030]\]. Male gender, and lower education level were, as well as being predictors of non-response at baseline, also predictors of loss to follow-up, which is also in line with findings from previous studies \[[@pone.0218658.ref017], [@pone.0218658.ref031]\]. In contrast to other STI studies, we found that individuals who reported STI-related symptoms were less likely to participate at baseline. This might be explained by the differences in the study design. Participants in two other Dutch STI studies \[[@pone.0218658.ref005], [@pone.0218658.ref030]\], received a free chlamydia test kit if they agreed to participate, which might have provided extra motivation for individuals with STI-related symptoms to participate. In our study, participation was not required to receive the first STI test, as individuals who were invited to participate had already made an appointment for an STI test at the clinic.

We found that chlamydia positivity rates were significantly higher in non-respondents compared to participants at baseline, while individuals reporting a higher number of partners in the past six months, (classically categorized as high-risk \[[@pone.0218658.ref032], [@pone.0218658.ref033]\]), participated more than individuals reporting lower number of partners. A possible explanation for this contradiction might be that non-respondents, although having fewer partners, more often reported condomless sex at last sexual contact, STI-related symptoms, and being notified by their partner, which are also known risk factors for chlamydia infection \[[@pone.0218658.ref034]\]. Condomless sex at last sexual contact should, however, be interpreted with caution, as reporting condomless sex in a monogamous relationship does not necessarily reflect higher chlamydia risk \[[@pone.0218658.ref035]\].

Low perceived importance of health at baseline was a predictor of long-term loss to follow-up (at six-month and one-year follow-up) in all STI clinic regions. This finding might be related to earlier findings that showed that long-term health goals might influence certain behaviors, such as participation behavior (i.e., motivation to participate in health research) \[[@pone.0218658.ref036], [@pone.0218658.ref037]\]. In non-Amsterdam, high intentions towards condom use and STI testing at baseline and high impulsiveness were predictors of loss to follow-up, and in Amsterdam, less positive attitudes regarding prevention of chlamydia and lower social norms and support were associated with loss to follow-up. These results partly reflect the theory of planned behavior, that links attitudes and social norms to intended behavior \[[@pone.0218658.ref038]\], and with previous studies that found that individuals are not always able to carry out intended behavior \[[@pone.0218658.ref039]--[@pone.0218658.ref041]\]. Low perceived risk of chlamydia at baseline was associated with loss to follow-up at six-month and one-year follow-up in non-Amsterdam, which is in line with the health belief model (i.e., perceived seriousness/susceptibility associated with likelihood of engaging in behavior \[[@pone.0218658.ref042]\]) and has previously been described as the main reason for non-response \[[@pone.0218658.ref010]\]. However, in Amsterdam, high risk perception was a predictor of loss to follow-up. A possible explanation for this contradictory finding is that we examined the association between risk perception at baseline and loss to follow-up one year later, and not risk perception after one year. It might be that risk perception decreased after baseline in Amsterdam, because individuals believed they were engaging in less risky sexual behavior than before or they believed they overestimated their risk at baseline \[[@pone.0218658.ref043]\]. Lower risk perception at the follow-up moments might have negatively influenced the motivation to participate in the follow-up moments.

The findings of this study indicate that to prevent non-response bias, recruitment strategies should put more effort into recruiting underrepresented behavioral and demographic groups in sexual health-related research. For example, targeted recruitment or cultural adaptations (e.g., flyers and/or personalized invitations adapted to migrants\' culture and language) \[[@pone.0218658.ref044]\], or adapting the recruitment method to increase interest and motivation among males (e.g., raising awareness or a greater sense of responsibility in terms of health in males) \[[@pone.0218658.ref029]\], might be effective in improving response rates in these underrepresented groups. Furthermore, the psychological predictors of loss to follow-up identified in this study could also be used as potential targets for recruitment strategies to increase retention. Recruitment strategies focusing on increasing perceived importance of health (i.e., health goals) by stimulating (health) goal pursuit \[[@pone.0218658.ref036], [@pone.0218658.ref037]\], or improving perceived risk \[[@pone.0218658.ref045]\] using risk communication targeting different elements of risk perception simultaneously (e.g., perceived severity and self-efficacy) \[[@pone.0218658.ref046]\], might increase response rates and retention in sexual health-related research. Moreover, implementation intentions (i.e., formulating a specific plan or *implementation intention*) might be an effective strategy to improve participation behavior, as it targets a variety of factors related to (intended) behavior \[[@pone.0218658.ref039]\], including the different psychological predictors of loss to follow-up identified in this study. Future research should be undertaken to investigate the impact of targeted recruitment strategies on response and retention in underrepresented demographic, behavioral, and psychological groups.

In conclusion, differences in demographic, behavioral, and psychological characteristics need to be taken into consideration in recruitment strategies. Tailoring recruitment strategies to demographic characteristics, behavioral, and psychological characteristics, might be needed to increase response rates and retention, and to prevent non-response bias in health research.
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